ESPR EBITDA Margin

Esperion Therapeutics Inc · EBITDA Margin

ESPR logo

ESPR EBITDA Margin

Latest reported9.54%
ESPR EBITDA Margin (0.00% → 9.54%)
High-resolution chart · PNG

ESPR ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
15.8428%
2.2777%
-129.0319%
-233.6522%
-283.1759%
-52.8831%
-59.8029%
-110.7582%
0%
0%
0%
0%
-0.4559%
0%
0%
0%
0%
-1,276,100%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.